Audax Adds to Belmont Instrument
Search
Share on twitter
Share on linkedin
Share on print
Share on email

Audax Adds to Belmont Instrument

Belmont Instrument, a portfolio company of Audax Private Equity since December 2017, has acquired the product lines of MTRE Advanced Technologies from Mennen Medical.

MTRE is a medical technology company that develops, manufactures and markets non-invasive solutions for body temperature control. The company’s product lines include the Allon system and ThermoWrap disposable garment which are used to control a patient’s temperature during surgery; CritiCool, a system used to induced hypothermia; and CritiCool Pro, an integrated temperature management and patient monitoring system.

MTRE’s products are used in a range of medical applications including cardio-vascular, organ transplant, pediatric, neurosurgery, and trauma, as well as in the evolving application of neuroprotective cooling therapy for stroke, cardiac arrest and traumatic brain injuries. MTRE is headquartered in Rehovot, Israel (www.mtre.com).

Belmont’s blood and fluid warming systems are used globally in war zones, hospitals, ambulances, flight line helicopters, ski patrols or anywhere warm blood and fluids are needed. Belmont’s leading product is The Belmont Rapid Infuser RI-2 – more commonly referred to as “The Belmont” – which uses electromagnetic induction heating to provide control of temperature and infusion during fluid resuscitation. The product is credited with saving thousands of lives by infusing warm blood and fluid into patients experiencing massive blood loss, while air removal features help keep the patient safe from air embolisms. The Belmont is used for high-volume infusions in operating rooms, emergency and critical care, labor and delivery, pediatric departments, and military hospitals.

Belmont’s acquisition of MTRE extends its portfolio to include non-invasive body temperature management products and advances the company’s strategy to invest in technologies that leverage the company’s existing product portfolio and sales channels. “This transaction is the first among several planned strategic acquisitions for Belmont as we build out a strong global product portfolio to better support clinicians and leverage our core strengths in anesthesiology, critical care and trauma to broaden the availability of these products in the market,” said Brian Ellacott, Chief Executive Officer of Belmont.

Belmont was founded in 1980 by Dr. George Herzlinger and has 80 employees with a headquarters near Boston in Billerica, MA (www.belmontinstrument.com).

Audax Group makes control investments of $10 million to $100 million in middle market companies with transaction values of $25 million to $500 million. Sectors of interest include industrial manufacturing; energy; outsourced industrial services; consumer products; healthcare devices and services; non-asset based logistics; technology; aerospace & defense; business services; and direct marketing. The firm was founded in 1999 and has offices in Boston, New York and Menlo Park (www.audaxgroup.com).

Mennen Medical Group, the seller of MTRE, is a provider of patient monitoring, diagnostic instrumentation, and clinical information systems used in hospitals for cardiac catheterization and other critical care applications. The company is based in Rehovot, Israel (www.mennenmedical.com).

© 2018 Private Equity Professional | June 21, 2018

Share on twitter
Share on linkedin
Share on print
Share on email

To search in site, type your keyword and hit enter